A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples